Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany

References

• Seneviratne U, De Silva R. Lambert-Eaton myasthenic syndrome. Postgrad Med J 1999;75:516-20
   PubMed Web of Science ®Google Scholar
• Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc 1957;163:1117-24
   PubMed Web of Science ®Google Scholar
• Stickler DE, Huff JS, Kleinschmidt P. Lambert-Eaton Myasthenic Syndrome. 2010. http://emedicine.medscape.com/article/792803. [Last accessed 19 January 2012]
   Google Scholar
• O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-96
   PubMed Web of Science ®Google Scholar
• Wirtz PW, Bradshaw J, Wintzen AR, et al. Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families. J Neurol 2004;251:1255-9
   Google Scholar
• Wirtz PW, Nijnuis MG, Sotodeh M, et al; Dutch Myasthenia Study Group. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol 2003;250:698-701
   PubMed Web of Science ®Google Scholar
• Plaghi OW, Das J-P. Lambert-Eaton-Myasthenie Syndrom. Freiburg: Deutsche Gesellschaft für Muskelkranke e.V. DGM, 2011
   Google Scholar
• Wirtz PW, Sotodeh M, Nijnuis M, et al. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 2002;73:766-8
   PubMed Web of Science ®Google Scholar
• Wirtz PW, Smallegange TM, Wintzen AR, et al. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002;104:359-63
   PubMed Web of Science ®Google Scholar
• Pellkofer HL, Armbruster L, Linke R, et al. Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients. J Neuroimmunol 2009;217:90-4
   PubMedGoogle Scholar
• Winter Y, Schepelmann K, Spottke AE, et al. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010;257:1473-81
   PubMed Web of Science ®Google Scholar
• Kobelt G, Lindgren P, Smala A, et al. The German Cost of MS Study Group. Costs and quality of life of multiple sclerosis: an observational study in Germany. Eur J Health Econ 2001;2:60-8
   Google Scholar
• Sharshar T, Chevret S, Mazighi M, et al. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol 2000;247:286-90
   PubMed Web of Science ®Google Scholar
• Sieb JP, Kraner S, Köhler W, et al. Myasthenia gravis und myasthene Syndrome. Deutsches Ärzteblatt 2011;97(Heft 51–52):A3496-500
   Google Scholar
• Winter Y, Schepelmann K, Spottke AE, et al. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010;257:1473-81
   PubMed Web of Science ®Google Scholar
• Work productivity and activity impairment questionnaire. http://www.reillyassociates.net/WPAI-SHP-PSO-German__Germany__V1.2.doc. [Last accessed 19 January 2012]
   Google Scholar
• Greiner W, Claes C, Busschbach JJ, et al. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005;6:124-30
   PubMedGoogle Scholar
• Titulaer MJ, Wirtz PW, Kuks JB, et al. The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients. J Neuroimmunol 2008;201–202:153-8
   PubMedGoogle Scholar
• Maddison P, Lang B, Mills K, et al. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry 2001;70:212-7
   PubMed Web of Science ®Google Scholar
• Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J 2007;16:22-7
   PubMedGoogle Scholar
• Groen H, van der Bij W, Koëter GH, et al. Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am J Transplant 2004;4:1155-62
   PubMed Web of Science ®Google Scholar
• Dyer MT, Goldsmith KA, Sharples LS, et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13
   PubMed Web of Science ®Google Scholar
• Twork S, Wiesmeth S, Klewer J, et al. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 2010;8:129
   PubMed Web of Science ®Google Scholar
• Survey of the delay in diagnosis for 8 rare diseases in Europe (EURORDISCARE 2). http://www.eurordis.org/sites/default/files/publications/Fact_Sheet_Eurordiscare2.pdf. [Last accessed 19 January 2012]
   Google Scholar
• Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010;17:893-902
   PubMed Web of Science ®Google Scholar
• Lurie F, Kistner RL. In prospective study using Specific Quality of Life & Outcomes Response-Venous (SQOR-V) questionnaire the recall bias had the same magnitude as the minimally important difference. Qual Life Res 2011;20:1589-93
   Google Scholar
• McPhail S, Beller E, Haines T. Physical function and health-related quality of life of older adults undergoing hospital rehabilitation: how strong is the association? J Am Geriatr 2010;58:2435-7
   Google Scholar